× KTN KTN News KTN Morning Express KTN Leo Leo Mashinani The Big Story Checkpoint News Center E-Paper Lifestyle & Entertainment Nairobian Entertainment Eve Woman Travelog TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise VAS E-Learning Digger Classified Jobs Games Crosswords Sudoku The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS
Show Swahili

Pfizer and Biontech begin clinical trials of a new Covid vaccine targeting the Omicron variant

26th January, 2022

Pfizer and Biontech have begun clinical trials of a new Covid vaccine – which specifically targets the omicron variant.

The trials will be conducted as a new vaccine and booster jabs on around 1 thousand 4 hundred people. There could be some allergic reactions expected.